Steffen Schuster, ITM CEO

Ger­man ra­dio­phar­ma nabs €188M to boost iso­tope man­u­fac­tur­ing, ad­vance can­cer pipeline

Ra­dio­phar­ma com­pa­ny and ra­dioiso­tope sup­pli­er ITM, or Iso­topen Tech­nolo­gien München, raised €188 mil­lion ($204 mil­lion) to boost in-house man­u­fac­tur­ing of lutetium-177 as well as to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.